首页> 美国卫生研究院文献>Journal of Clinical Medicine >Re-Evaluating the Protective Effect of Hemodialysis Catheter Locking Solutions in Hemodialysis Patients
【2h】

Re-Evaluating the Protective Effect of Hemodialysis Catheter Locking Solutions in Hemodialysis Patients

机译:重新评估血液透析导管锁定液对血液透析患者的保护作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Catheter-related bloodstream infections (CRBSIs) and exit-site infections (ESIs) are common complications associated with the use of central venous catheters for hemodialysis. The aim of this study was to analyze the impact of routine locking solutions on the incidence of CRBSI and ESI, in preserving catheter function, and on the rate of all-cause mortality in patients undergoing hemodialysis. We selected publications (from inception until July 2018) with studies comparing locking solutions for hemodialysis catheters used in patients undergoing hemodialysis. A total of 21 eligible studies were included, with a total of 4832 patients and 318,769 days of catheter use. The incidence of CRBSI and ESI was significantly lower in the treated group (citrate-based regimen) than in the controls (heparin-based regimen). No significant difference in preserving catheter function and all-cause mortality was found between the two groups. Our findings demonstrated that routine locking solutions for hemodialysis catheters effectively reduce the incidence of CRBSIs and ESIs, but our findings failed to show a benefit for preserving catheter function and mortality rates. Therefore, further studies are urgently needed to conclusively evaluate the impact of routine locking solutions on preserving catheter function and improving the rates of all-cause mortality.
机译:导管相关的血流感染(CRBSI)和出口部位感染(ESI)是与使用中央静脉导管进行血液透析相关的常见并发症。这项研究的目的是分析常规锁定解决方案对CRBSI和ESI发生率,保留导管功能以及血液透析患者全因死亡率的影响。我们选择了一些出版物(从开始到2018年7月),进行了比较血液透析患者使用的血液透析导管锁定溶液的研究。总共纳入21项合格研究,共有4832名患者和318,769天的导管使用时间。在治疗组(基于柠檬酸盐的方案)中,CRBSI和ESI的发生率显着低于对照组(基于肝素的方案)。两组之间在保留导管功能和全因死亡率方面无显着差异。我们的研究结果表明,常规的血液透析导管锁定解决方案可有效降低CRBSI和ESI的发生率,但我们的研究结果未能显示出保持导管功能和死亡率的益处。因此,迫切需要进一步的研究来最终评估常规锁定解决方案对保持导管功能和提高全因死亡率的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号